NYSTATIN- nystatin oral suspension suspension
TriRx Huntsville Pharmaceutical Services, LLC
----------
Nystatin Oral Suspension, USP
NYSTATIN
nystatin oral suspension suspension |
| Product Information |
| Product Type | HUMAN PRESCRIPTION DRUG | Item Code (Source) | NDC: 80432-003 |
| Route of Administration | ORAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| NYSTATIN (UNII: BDF1O1C72E) (NYSTATIN - UNII:BDF1O1C72E) | NYSTATIN | 100000 [USP'U] in 1 mL |
|
|
|
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC: 80432-003-33 | 473 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product | 02/01/2020 | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| ANDA | ANDA065148 | 02/01/2020 | |
|
| Labeler - TriRx Huntsville Pharmaceutical Services, LLC
(117090286)
|
| Establishment |
| Name | Address | ID/FEI | Business Operations |
| TriRx Huntsville Pharmaceutical Services, LLC | | 117090286 | manufacture(80432-003) |
TriRx